FDA OKs Paradise Renal Denervation System for Hypertension
After a positive FDA panel review in August, the FDA has approved the Paradise Ultrasound Renal Denervation system for the treatment of hypertension, manufacturer Recor and parent company Otsuka announced.
United States Naomi Fisher Division Of Endocrinology Recor Medical Inc Drug Administration Harvard Medical School
Source: medscape.com